摘要
胰腺癌是恶性程度非常高、预后非常差的消化道肿瘤之一。大部分患者发现时已属无法手术切除的晚期胰腺癌,并对放化疗不敏感。最近的研究表明胰腺癌干细胞是胰腺癌发生和进展的源头,并对放疗和化疗导致的凋亡耐受,对胰腺癌干细胞自我更新和耐药机制的深入研究可能发现对胰腺癌更有效的治疗措施。现对胰腺癌干细胞研究现状作一综述。
出处
《中华细胞与干细胞杂志(电子版)》
2011年第2期53-55,共3页
Chinese Journal of Cell and Stem Cell(Electronic Edition)
参考文献19
-
1Jennifer L. Dembinski,Stefan Krauss.Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma[J]. Clinical & Experimental Metastasis . 2009 (7)
-
2Thilo Welsch,Shereen Keleg,Frank Bergmann,Luca Degrate,Sonja Bauer,Jan Schmidt.Comparative analysis of tumorbiology and CD133 positivity in primary and recurrent pancreatic ductal adenocarcinoma[J]. Clinical & Experimental Metastasis . 2009 (7)
-
3Ami N. Shah,Justin M. Summy,Jing Zhang,Serk In Park,Nila U. Parikh,Gary E. Gallick.Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells[J]. Annals of Surgical Oncology . 2007 (12)
-
4Li C,Heidt DG,Dalerba P, et al.Identification of pancreatic cancer stem cells. Cancer Research . 2007
-
5PC Hermann,SL Huber,T Herrler.Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell . 2007
-
6Berman DM,Karhadkar SS,Maitra A,et al.Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature . 2003
-
7Lee CJ,Dosch J,Simeone DM.Pancreatic cancer stem cells. Journal of Clinical Oncology . 2008
-
8Bailey JM,Mohr AM,Hollingsworth MA.Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncegene . 2009
-
9Lee CJ,Li C,Simeone DM.Human pancreatic cancer stem cells:im-plications for how we treat pancreatic cancer. Transl Oncol . 2008
-
10C Martínez-Romero,I Rooman,A Skoudy,C Guerra,X Molero,A González,M Iglesias,T Lobato,A Bosch,M Barbacid,FX Real,I Hernández-Mu?oz.The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma. Journal of Paleopathology . 2009
二级参考文献26
-
1[1]Bardeesy N,DePinho RA.Pancreatic cancer biology and genetics.Nat Rev Cancer 2002; 2:897-909
-
2[2]Murphy SL.Deaths:final data for 1998.Natl Vital Stat Rep 2000; 48:101-105
-
3[3]Cameron JL,Crist DW,Sitzmann JV,Hruban RH,Boitnott JK,Seidler AJ,Coleman J.Factors influencing survival after pancreaficoduodenectomy for pancreatic cancer.Am J Surg 1991; 161:120-124; discussion 124-125
-
4[4]Niederhuber JE,Brennan MF,Menck HR.The National Cancer Data Base report on pancreatic cancer.Cancer 1995;76:1671-1677
-
5[5]Jemal A,Thomas A,Murray T,Thun M.Cancer statistics,2002.CA Cancer J Clin 2002; 52:23-47
-
6[6]Bjerkvig R,Tysnes BB,Aboody KS,Najbauer J,Terzis AJ.Opinion:the origin of the cancer stem cell:current controversies and new insights.Nat Rev Cancer 2005; 5:899-904
-
7[7]Al-Hajj M,Wicha MS,Benito-Hernandez A,Morrison SJ,Clarke MF.Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci USA 2003; 100:3983-3988
-
8[8]Singh SK,Clarke ID,Terasaki M,Bonn VE,Hawkins C,Squire J,Dirks PB.Identification of a cancer stem cell in human brain tumors.Cancer Res 2003; 63:5821-5828
-
9[9]Galli R,Binda E,Orfanelli U,Cipelletti B,Gritti A,De Vitis S,Fiocco R,Foroni C,Dimeco F,Vescovi A.Isolation and characterization of tumorigerfic,stem-like neural precursors from human glioblastoma.Cancer Res 2004; 64:7011-7021
-
10[10]Collins AT,Berry PA,Hyde C,Stower MJ,Maitland NJ.Prospective identification of tumorigenic prostate cancer stem cells.Cancer Res 2005; 65:10946-10951
共引文献19
-
1庄晓虹,张世能.胰腺癌干细胞的研究进展[J].岭南现代临床外科,2009,9(2):106-108.
-
2刘俊,裘正军,庄瑜,钟福全.干细胞在胰腺癌中的研究进展[J].现代生物医学进展,2009,9(14):2752-2755. 被引量:2
-
3沈俊,王敏,刘文松,秦仁义.体外侵袭和化疗干预富集PANC1中CD24^+CD44^+细胞群的初步研究[J].中华胰腺病杂志,2009,9(5):347-349.
-
4安勇,姚捷,卫积书,陆子鹏,蔡辉华,戴存才,钱祝银,徐泽宽,苗毅.胰腺癌细胞株PANC-1中肿瘤干细胞的体外耐药性研究[J].外科理论与实践,2010,15(1):7-11. 被引量:2
-
5黄鹏,王春友,吴河水,熊炯炘.Notchl信号系统对胰腺癌干细胞增殖与分化的调控[J].中华肝胆外科杂志,2010,16(5):359-362. 被引量:1
-
6巫丽丽,罗佐杰.肿瘤干细胞与内分泌肿瘤[J].中国基层医药,2010,17(20):2852-2854.
-
7徐飞,吴强,孙志华,沈婕红,赵燕.宫颈癌中Ezrin和CD44-V6的表达及其相关性[J].江苏医药,2010,36(21):2494-2496. 被引量:5
-
8宣广旭,何晓松.CD44基因与鼻咽癌关系的研究进展[J].临床医学工程,2011,18(2):310-311.
-
9卢佳,杨永秀,高丽,杨爱宏.CD44v6与人乳头瘤病毒在宫颈鳞癌及癌前病变中的相关性研究[J].国际妇产科学杂志,2012,39(1):100-102. 被引量:4
-
10朱皓,于晓红.卵巢黏液性肿瘤中EGFR和CD44V6的表达及意义[J].南昌大学学报(医学版),2012,52(1):25-28.
同被引文献13
-
1王利,魏品康,秦志丰,徐永平,楼丽广,李玉莉,何金.葛根素注射液逆转人胃癌裸鼠原位移植瘤多药耐药性的实验研究[J].成都中医药大学学报,2005,28(1):42-44. 被引量:5
-
2谢勇,王建宾.参麦注射液对白血病细胞多药抗药性逆转作用的实验研究[J].大同医学专科学校学报,2005,25(2):3-5. 被引量:14
-
3陈立武,林晶,陈文,张伟平.中药治疗原发性肝癌Ⅲ期围手术期患者42例[J].中国中西医结合杂志,2005,25(9):832-834. 被引量:51
-
4Chiba T, Kita K, ZhengYW, et al. Side Population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties [J]. Hepatology, 2006, 44 (1) :240-251.
-
5Hu L, McArthur C, Jaffe RB. Ovarian cancer stem-like side-population cells are tumorigenic and chemoresistant [J]. Br J cancer, 2010, 102(8): 1276-1283.
-
6Huan S, Pazdur R, Singhakowinta A, et al. Low-dose continuous infusion 5-fluorouracil evaluation in advanced breast carcinoma [J]. Cancer, 1989, 63(3):419-422.
-
7Zhou S, Schuetz JD, Bunting KD, et al. The ABC transproter Bcrpl/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side- population phenotype [J]. Nat Med, 2001, 7(9): 1028-1034.
-
8贾茜.肝癌干细胞筛选及Oct4、ABCG2对其耐药性影响的初步研究[D].重庆医科大学,2012.
-
9柏茂树,伍治平,王熙才.肿瘤化疗辅助中药研究进展[J].现代肿瘤医学,2010,18(3):597-601. 被引量:48
-
10曹治云,陈旭征,林瀛,杜建.中药复方对肝癌移植瘤小鼠肿瘤干细胞表面标志c-kit和CD_(133)表达的影响[J].福建中医学院学报,2010,20(3):18-21. 被引量:18
二级引证文献10
-
1陈旭征,黎金浓,胡海霞,魏丽慧,廖联明,杜建.解毒消癥饮对肝癌侧群细胞增殖和相关因子表达的影响[J].中华细胞与干细胞杂志(电子版),2014,4(3):41-45. 被引量:2
-
2郑飞,周文平,张巍,赵正维.大鼠肝癌诱导过程中肝癌干细胞标志及炎症因子的动态变化[J].中国组织工程研究,2015,19(19):3005-3009. 被引量:12
-
3胡海霞,陈旭征,曹治云,廖联明,杜建.解毒消癥饮对肝癌干细胞标记分子CD90和CD133表达的影响[J].实用中西医结合临床,2015,15(5):80-82. 被引量:6
-
4陈修平,唐正海,石哲,陆金健,苏焕兴,陈新,王一涛.肿瘤生物学研究热点与抗肿瘤中药研发策略[J].中国中药杂志,2015,40(17):3416-3422. 被引量:13
-
5孙菲.中药抗肿瘤作用及机制研究进展[J].中国民族民间医药,2016,25(17):48-50. 被引量:2
-
6梁淑芳,刘栋,程彬彬.中药复方治疗原发性肝癌实验研究进展[J].辽宁中医药大学学报,2017,19(8):152-155. 被引量:6
-
7董孟佳,许尤琪,方祯.中药复方治疗肝癌机理的实验研究进展[J].环球中医药,2017,10(10):1270-1273. 被引量:11
-
8花慧,沙秀秀,姜雨辰,陈少军,马舒伟.基于网络药理学和分子对接技术的“乳香-没药”抑制肿瘤的作用机制探讨[J].海峡药学,2022,34(1):24-28. 被引量:2
-
9胡泽玉,杨清瑞,周铖,杨林,肖海娟,方瑜.肝癌化疗耐药机制及中药干预研究进展[J].中国实验方剂学杂志,2022,28(14):254-261. 被引量:14
-
10白裕海,魏开建(指导).魏开建教授运用解毒消癥饮方治疗正虚热毒证恶性肿瘤的经验[J].中国民族民间医药,2022,31(18):88-92. 被引量:3
-
1郝延璋,叶艳,谢奇朋,张旭东,张林杰.顺铂诱导凋亡耐受胃腺癌细胞坏死性死亡[J].安徽医科大学学报,2006,41(1):4-7. 被引量:3
-
2肖光莉.手术与术后放疗之间的间隔时间对预后的影响[J].华夏医药,2005,9(3):217-220.
-
3于则利.胆囊癌早期诊断与治疗源头疾病的探讨[J].华夏医药,2007,2(4):262-264.
-
4王雪平,罗玉贤,马亮亮,顾福杭,赫建平,陈娟.TRAIL受体DR4、DR5、DcR1在结肠癌中的表达及意义[J].河北医药,2011,33(14):2090-2091. 被引量:1
-
5陈卫强,戚好文,吴昌归,李志奎,柏长青,张艰.双氢青蒿素和顺铂诱导人肺腺癌A549/CDDP细胞凋亡[J].现代肿瘤医学,2007,15(5):616-619. 被引量:11
-
6滕凤猛,吴穷,陈昌杰.缺氧诱导因子-1α调控肝癌细胞对奥沙利铂耐药的机制[J].肿瘤防治研究,2014,41(11):1176-1180. 被引量:9
-
7王勤章,王蓉,丁国富,李令勋,张国玺,倪钊,李应龙.膀胱移行细胞癌COX-2表达及其与肿瘤细胞增殖和凋亡的关系[J].中国医师杂志,2004,6(6):786-789. 被引量:5
-
8非编码RNA是控制癌干细胞生物学机制的重要分子机制[J].中国药科大学学报,2008,39(1):96-96.
-
9范瑞华,李惠民,李晓进,喻镁佳,金从国.白血病细胞系K562侧群细胞的分选及其初步研究[J].中华血液学杂志,2010,31(6):418-420. 被引量:1
-
10栗家平,杨小龙.Bmi-1与消化系统肿瘤相关性研究进展(文献综述)[J].放射免疫学杂志,2011,24(1):57-60. 被引量:1